Founded in 2019, Rivaara Labs operates in the Health Tech sector offering a wide network of specialized Molecular Diagnostics labs as part of the Bharat Daftary group of companies. The company is focu...
Funding stage:
Private Equity
Last funding:
25/08/2025
Total funding:
$19.07 Mn+
Revenue:
Investors
Employee count:
134
Last 90d
134
Last 90d
Web traffic:
350
350
Last 30d
Last 30d
Rivaara Labs: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders8
Latest Filing Date17 Aug 2023- Funding Events12
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Rivaara Labs
As of 18 August 2023, Rivaara Labs's equity is held by 7 shareholders, with the top three being Bharat Daftary, Amicus Capital Private Equity I LLP, and Siddharth Daftary.
Bharat Daftary holds the largest stake in Rivaara Labs at 49.8% as of 18 August 2023.
As of 18 August 2023, founders collectively hold 49.8% equity in Rivaara Labs.
As of 18 August 2023, investors collectively hold 32.6% equity in Rivaara Labs.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links